Skip to main content

Table 2 Primer sequences

From: Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?

Gene

Forward

Reverse

TG2

5’AGAGGAGCGGCAGGAGTATG 3’

5’AGGATCCCATCTTCAAACTGC 3’

GAPDH

5’TCAAGGGCATCCTGGGCTAC 3’

5’CGTCAAAGGTGGAGGAGTGG 3’

POLR2F

5’GAACTCAAGGCCCGAAAG 3’

5’TGATGATGAGCTCGTCCAC 3’

IL-1β

5’TACAGCTGGAGAGTGTAGATC 3’

5’CAAATTCCAGCTTGTTATTG 3’

TNF-α

5’CCCAGGCAGTCAGATCATCTTC 3’

5’CTCTCAGCTCCACGCCATTG 3’

IL-1ra

5’TCATCCGCTCAGACAGTGGC 3’

5’AGCTTCCATCGCTGTGCAGA 3’

TGF-β1

5’CTTTCCTGCTTCTCATGGCC 3’

5’CCGTGGAGCTGAAGCAATAG 3’

β1 integrin

5’TGTGGAGGAAATGGTGTTTGC 3’

5’TCTGTCCGTTGCTGGCTTCA 3’

β3 integrin

5’CAATGCCACCTGCCTCAACA 3’

5’GAGTCTTCATAGTACTGGAATC 3’

MMP-2

5’AAGGCCAAGTGGTCCGTGTG 3’

5’GTGCAGCTGTTGTACTCCTTGC 3’

  1. TG2 Transglutaminase 2, GAPDH glyceraldehyde-3-phosphate-dehydrogenase, POLR2F polymerase (RNA) II polypeptide F, IL-1β interleukin-1β, TNF-α tumor necrosis factor-α, IL-1ra interleukin-1 receptor antagonist, TGF-β transforming growth factor-β1, MMP-2 matrix metalloproteinase s2